Secura Bio
PrivateLast Round
Debt
Mar 5, 2019
Total Funding Raised
$145M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Secura Bio operates in Healthcare & Life Sciences and is based in Berkeley Heights, New Jersey. Its latest recorded funding round was a Debt round in March 2019.
Secura Bio is a biopharmaceutical company that develops and commercializes oncology therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Secura Bio Comparables
Compare Secura Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Yingli Pharmaceutical Co., Ltd. | 79% | |
| AbbVie | 77% | |
| TG Therapeutics | 77% |
For institutional investors. Book with your work email.
Secura Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 5, 2019 | ||||
| Early Funding | Mar 5, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Secura Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Athyrium Capital Management | Debt, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 60, 103% of headcount.
- Jul 25, 2026
Monthly visitors grew 77% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 4, 2026
Secura Bio, Inc presents two duvelisib posters at the 2026 American Society of Hematology (ASH) Annual Meeting in Louisiana in Dec '26, including findings from the Phase 2 PRIMO study and a Phase 1 topical formulation study.
For institutional investors. Book with your work email.
Secura Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Secura Bio's valuation, stock price, and market status.
Is Secura Bio a public or private company?
Secura Bio is a private company.
What is the current stock price of Secura Bio?
Secura Bio is a private company, so its shares have no public market price. Caplight tracks Secura Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Secura Bio worth (valuation)?
Valuation information for Secura Bio is not publicly available.
Can I buy Secura Bio stock?
Secura Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Secura Bio's last funding round?
Secura Bio's most recent funding round was Debt on March 5, 2019.
Who are the main investors in Secura Bio?
Key investors in Secura Bio include Athyrium Capital Management.
Will Secura Bio IPO soon?
No public IPO plans have been announced for Secura Bio.
How can I track Secura Bio secondary market activity?
Caplight tracks bids, offers, and trades in Secura Bio's shares on secondary markets.